Impact of early abciximab administration on myocardial reperfusion in patients with ST-segment elevation myocardial infarction pretreated with 600 mg of clopidogrel before percutaneous coronary intervention

By Dudek Dariusz   Rakowski Tomasz   Bartus Stanislaw   Giszterowicz Dawid   Dobrowolski Wojciech   Zmudka Krzysztof   Zalewski Jaroslaw   Ochala Andrzej   Wieja Pawel   Janus Bogdan   Dziewierz Artur   Legutko Jacek   Bryniarski Leszek   Dubiel Jacek  

Journal of Thrombosis and Thrombolysis, Vol. 30, Iss. 3, 2010-10 ,pp. : 347-353

Springer Publishing Company

Access to resources Recommend Favorite

Complications of chronic total occlusion percutaneous coronary intervention

By Patel Yogesh   Depta Jeremiah P   DeMartini Tony J  

Interventional Cardiology, Vol. 5, Iss. 5, 2013-10 ,pp. : 567-575

Future Medicine

Access to resources Recommend Favorite

Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment

By Iijima Raisuke  

Clinical Research in Cardiology, Vol. 97, Iss. 3, 2008-03 ,pp. : 160-168

Springer Publishing Company

Access to resources Recommend Favorite

The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary

By  

Current Cardiology Reviews, Vol. 4, Iss. 4, 2008-11 ,pp. : 293-299

Bentham Science Publishers

Access to resources Recommend Favorite

Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention

By Barillà Francesco  

Platelets, Vol. 24, Iss. 3, 2013-05 ,pp. : 183-188

Informa Healthcare

Access to resources Recommend Favorite